Survey Findings on GLP-1 Prescribing Practices

This report presents findings from a survey conducted by Omada Health, focusing on the attitudes of over 2,000 U.S. primary care physicians (PCPs) regarding GLP-1 medications for weight loss. The survey reveals that a significant majority of PCPs believe that GLP-1s should be accompanied by dietary and exercise changes to effectively promote healthy weight loss. Concerns were raised about the risks associated with third-party telehealth prescribers, with 67% of PCPs agreeing that such practices may jeopardize patient health. The report highlights that only 18% of respondents felt comfortable with patients using these services for GLP-1 prescriptions. Additionally, the survey indicates that many physicians advise against compounded GLP-1s due to perceived safety and regulatory issues. The findings emphasize the importance of lifestyle modifications and the role of primary care in managing patient health, particularly in the context of increasing GLP-1 prescriptions through telehealth channels.